title: International harmonisation of anthelmintic efficacy guidelines (Part 2).
abstract: The "International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)" is an international programme of co-operation between regulatory authorities and the animal health industries of the European Union, Japan and the United States of America which aims to harmonise the technical requirements for the registration of veterinary medicinal products. Australia and New Zealand participate as active observers. The objective of this second paper is to present additional guidelines established by the Working Group on anthelmintic guidelines: (1) efficacy of anthelmintics: specific recommendations for equine (VICH GL15), (2) efficacy of anthelmintics: specific recommendations for porcine (VICH GL16), (3) efficacy of anthelmintics: specific recommendations for canine (VICH GL19), (4) efficacy of anthelmintics: specific recommendations for feline (VICH GL20) and (5) efficacy of anthelmintics: specific recommendations for poultry (VICH GL21). These guidelines do not consist of rigid stipulations, but make clear recommendations on the minimal standards needed. To the veterinary profession, livestock producers and animal owners, harmonisation should mean quicker access to safer and more effective veterinary anthelmintics. In general, products should be relatively more affordable because of the reduction in registration costs and efficient use of resources by the regulatory authorities.
authors.affiliation: Faculty of Veterinary Medicine, Department of Parasitology and Parasitic Diseases, Ghent University, Salisburylaan 133, B9820 Merelbeke, Belgium. jozef.vercruysse@rug.ac.be
authors.forename: J
authors.initials: J
authors.lastname: Vercruysse
authors.forename: P
authors.initials: P
authors.lastname: Holdsworth
authors.forename: T
authors.initials: T
authors.lastname: Letonja
authors.forename: G
authors.initials: G
authors.lastname: Conder
authors.forename: K
authors.initials: K
authors.lastname: Hamamoto
authors.forename: K
authors.initials: K
authors.lastname: Okano
authors.forename: S
authors.initials: S
authors.lastname: Rehbein
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000592:standards* / Q000627:therapeutic use; D001315:Australia; D002371:Cat Diseases / Q000188:drug therapy / Q000469:parasitology; D002415:Cats; D002645:Chickens; D004283:Dog Diseases / Q000188:drug therapy / Q000469:parasitology; D004285:Dogs; D005062:European Union; D006374:Helminthiasis, Animal / Q000188:drug therapy*; D006734:Horse Diseases / Q000188:drug therapy / Q000469:parasitology; D006736:Horses; D007391:International Cooperation; D007564:Japan; D009520:New Zealand; D011201:Poultry Diseases / Q000188:drug therapy / Q000469:parasitology; D013045:Species Specificity; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy / Q000469:parasitology; D014481:United States; D019155:Veterinary Drugs / Q000592:standards* / Q000627:therapeutic use
chemical_list: D000871:Anthelmintics; D019155:Veterinary Drugs